共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R028380-25mg | 25mg | 5~7个工作日 |
AR-C155858 AR-C155858 |
95% |
|
|
罗恩 | R028380-50mg | 50mg | 5~7个工作日 |
AR-C155858 AR-C155858 |
95% |
|
|
罗恩 | R028380-5mg | 5mg | 5~7个工作日 |
AR-C155858 AR-C155858 |
95% |
|
|
罗恩 | R028380-10mg | 10mg | 5~7个工作日 |
AR-C155858 AR-C155858 |
95% |
|
|
阿拉丁 | A125208-5mg | 5mg | 现货 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
阿拉丁 | A125208-10mg | 10mg | 现货 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
阿拉丁 | A125208-25mg | 25mg | 现货 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
阿拉丁 | A125208-50mg | 50mg | 现货 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
阿拉丁 | A125208-1mg | 1mg | 现货 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
阿拉丁 | A125208-100mg | 100mg | 现货 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
凯为 | JZ00DC4Y-5mg | 5mg | 期货,请咨询 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-[(3,5-Dimethyl-1H-pyra... |
99% |
|
|
凯为 | JZ00DC4Y-10mg | 10mg | 期货,请咨询 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-[(3,5-Dimethyl-1H-pyra... |
99% |
|
|
凯为 | JZ00DC4Y-25mg | 25mg | 期货,请咨询 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-[(3,5-Dimethyl-1H-pyra... |
99% |
|
|
凯为 | JZ00DC4Y-50mg | 50mg | 期货,请咨询 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-[(3,5-Dimethyl-1H-pyra... |
99% |
|
|
凯为 | JZ00DC4Y-100mg | 100mg | 期货,请咨询 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-[(3,5-Dimethyl-1H-pyra... |
99% |
|
|
毕得 | BD305833-5mg | 5mg | 现货 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-((3,5-Dimethyl-1H-pyra... |
99% |
|
|
毕得 | BD305833-10mg | 10mg | 现货 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-((3,5-Dimethyl-1H-pyra... |
99% |
|
|
毕得 | BD305833-50mg | 50mg | 现货 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-((3,5-Dimethyl-1H-pyra... |
99% |
|
|
毕得 | BD305833-25mg | 25mg | 现货 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-((3,5-Dimethyl-1H-pyra... |
99% |
|
|
毕得 | BD305833-100mg | 100mg | 现货 |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基... (S)-6-((3,5-Dimethyl-1H-pyra... |
99% |
|
|
韶远 | SY027484-0.1g | 0.1g | 现货 |
(S)-1-异丁基-3-甲基-5-(4-羟基异噁唑烷-2... (S)-6-[(3,5-Dimethyl-4-pyraz... |
>95% |
|
|
Apollo | BISN0018-1mg | 1mg | 3-4周 |
AR-C155858 AR-C155858 |
|
|
|
Apollo | BISN0018-5mg | 5mg | 3-4周 |
AR-C155858 AR-C155858 |
|
|
|
Apollo | BISN0018-10mg | 10mg | 3-4周 |
AR-C155858 AR-C155858 |
|
|
|
源叶 | S85548-1mg | 1mg | 期货,请咨询 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
源叶 | S85548-5mg | 5mg | 期货,请咨询 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
源叶 | S85548-10mg | 10mg | 期货,请咨询 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
源叶 | S85548-25mg | 25mg | 期货,请咨询 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
源叶 | S85548-50mg | 50mg | 期货,请咨询 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
源叶 | S85548-100mg | 100mg | 期货,请咨询 |
AR-C155858,MCT1和MCT2抑制剂 AR-C155858 |
≥95% |
|
|
Target Mol | T14316-1mg | 1mg | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Target Mol | T14316-50mg | 50mg | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Target Mol | T14316-10mg | 10mg | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Target Mol | T14316-100mg | 100mg | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Target Mol | T14316-5mg | 5mg | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Target Mol | T14316-25mg | 25mg | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Target Mol | T14316-1mL | 1mL | 现货 |
化合物 AR-C155858 AR-C155858 |
99.42% |
|
|
Am | A373794-10mg | 10mg | 现货 |
AR-C155858 AR-C155858 |
98% |
|
|
Am | A373794-25mg | 25mg | 现货 |
AR-C155858 AR-C155858 |
98% |
|
|
Am | A373794-5mg | 5mg | 现货 |
AR-C155858 AR-C155858 |
98% |
|
|
Am | A373794-1mg | 1mg | 现货 |
AR-C155858 AR-C155858 |
98% |
|
|
MCE | HY-13248-25mg | 25mg | 现货 |
AR-C155858 AR-C155858 |
99.62% |
|
|
MCE | HY-13248-10mg | 10mg | 现货 |
AR-C155858 AR-C155858 |
99.62% |
|
|
MCE | HY-13248-10mM*1mL | 10mM*1mL | 现货 |
AR-C155858 AR-C155858 |
99.62% |
|
|
MCE | HY-13248-5mg | 5mg | 现货 |
AR-C155858 AR-C155858 |
99.62% |
|
|
MCE | HY-13248-1mg | 1mg | 现货 |
AR-C155858 AR-C155858 |
99.62% |
|
|